The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 303.00
Bid: 301.50
Ask: 304.00
Change: 3.00 (1.00%)
Spread: 2.50 (0.829%)
Open: 305.00
High: 305.00
Low: 300.50
Prev. Close: 300.00
IHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q4 Funds Under Direction Update

18 Oct 2022 07:00

RNS Number : 1697D
IntegraFin Holdings plc
18 October 2022
 

LEI Number: 213800CYIZKXK9PQYE87

 

 

18 October 2022

 

 

IHP Group quarterly update - Q4 of financial year 2022

 

 

Resilient Transact platform performance in spite of volatile markets

 

 

Headlines

 

 

· Highly resilient Transact platform gross inflows for the quarter of over £1.5bn, with solid net inflows during the quarter of over £0.7bn. 

 

· Net inflows to the Transact platform for the financial year ended 30 September 2022 of £4.4bn.

 

· Growth of the Transact platform's adviser base - at the end of the financial year (30 September 2022) there were 7.5k advisers registered on the Transact platform (an increase of over 5% from 30 September 2021).

 

· At the end of the financial year (30 September 2022) there were 224.7k clients on the Transact platform (an increase of 8% from 30 September 2021).

 

· The average (daily) funds under direction (FUD) on the Transact platform during the financial year ended 30 September 2022 was £52.5bn. This compares with an average during the prior financial year of £47.2bn.

 

· Other than the cost implications from the HMRC VAT decision (RNS issued on 20 September 2022), the detailed cost guidance, which we disclosed in the Q3 market update (19 July 2022), remains unchanged.

 

· The development of Time4Advice's CURO 365 software remains on schedule, and is planned for release to a beta client for live testing by the end of the year.

 

· The Transact-BlackRock Model Portfolio Service (MPS) was launched in September 2022. This is available exclusively to Transact platform clients.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter ended

30 September 2022

 

 

Quarter ended

30 September

2021

 

Financial year

ended

30 September 2022

 

Financial year

ended

30 September 2021

 

£m

Opening FUD

50,300

50,310

52,112

41,093

Inflows

1,505

1,967

7,275

7,695

Outflows

-785

-660

-2,873

-2,744

Net Flows

720

1,307

4,402

4,951

Market movements

-927

553

-6,248

6,297

Other movements(1)

-23

-58

-196

-229

Closing FUD

50,070

52,112

50,070

52,112

Average daily FUD for the period (£m)

52,217

51,647

52,544

47,240

Number of registered advisers

7,537

7,161

7,537

7,161

Number of platform clients

224,705

208,611

224,705

208,611

Notes:

 

(1) Includes fees, taxes and investment income.

 

 

 

Alex Scott, Chief Executive Officer, commented:

 

''I am very pleased with the strength of our business performance during the financial year ended 30 September 2022.

 

The Transact platform is utilised by clients and advisers for long term financial planning. Therefore, Transact platform outflows have remained relatively stable during the course of the year. This has contributed to our continued very high retention rate of funds under direction on the Transact platform of 94% for the financial year.

 

At a time of economic uncertainty, clients rely even more on the support and knowledge of their financial adviser. Our business model is centred on providing long term support for our clients and their financial advisers. We will continue to advance the development of our proprietary software, and we will train users in how to best use the extensive functionality now available. All of this will enable our clients, with their advisers, to stay on track with their long term financial plans.

 

We are mindful of the difficult economic environment and the significant volatility in asset markets, however we expect the performance of the Transact platform to remain robust during the forthcoming financial year, with new clients and advisers joining, and continued resilient flows onto the Transact platform.''

 

 

 

 

 

 

 

 

Historical information

 

 

£m

Q1

FY21

 

Q2

FY21

 

Q3

FY21

 

Q4

 FY21

 

Q1

FY22

 

Q2

FY22

 

Q3

FY22

Q4

FY22

 

Opening FUD

41,093

44,824

46,929

50,310

52,112

54,539

53,500

50,300

Inflows

1,581

2,153

1,994

1,967

1,976

2,092

1,703

1,505

Outflows

-741

-686

-657

-660

-688

-697

-703

-785

Net Flows

840

1,467

1,337

1,307

1,288

1,395

1,000

720

Market movements

2,938

694

2,112

553

1,207

-2,376

-4,152

-927

Other movements(1)

-47

-56

-68

-59

-68

-58

-48

-23

Closing FUD

44,824

46,929

50,310

52,112

54,539

53,500

50,300

50,070

 

Average daily FUD for the period (£m)

 

42,905

45,873

48,677

51,647

53,514

52,551

51,889

52,217

Number of registered advisers

6,836

6,962

7,056

7,161

7,278

7,356

7,469

7,537

Number of platform clients

194,857

201,104

205,532

208,611

213,178

218,787

221,992

224,705

Notes:

 

(1) Includes fees, taxes and investment income.

 

 

 

 

 

Enquiries

 

Investors

 

Luke Carrivick, IHP Head of Investor Relations

+44 020 7608 5463

 

Media

 

Lansons: Tony Langham

Lansons: Maddy Morgan-Williams

+44 (0)7979692287

+44 (0)7947364578

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMRBRTMTMBBLT
Date   Source Headline
23rd Apr 20241:49 pmRNSDirector/PDMR Shareholding
16th Apr 20247:15 amRNS2nd Quarter Results
22nd Mar 20242:31 pmRNSDirector/PDMR Shareholding
12th Mar 20243:49 pmRNSHolding(s) in Company
7th Mar 20244:45 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSResult of AGM
22nd Feb 20244:21 pmRNSDirector/PDMR Shareholding
30th Jan 20249:31 amRNSDirector/PDMR Shareholding
23rd Jan 20243:27 pmRNSAnnual Report and Notice of AGM
23rd Jan 20241:24 pmRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNS1st Quarter Results
10th Jan 202412:50 pmRNSHolding(s) in Company
8th Jan 20243:33 pmRNSDirector/PDMR Shareholding
5th Jan 20244:10 pmRNSDirector/PDMR Shareholding
22nd Dec 202311:52 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSFinal Results
24th Nov 202312:26 pmRNSCFO – commencement date of appointment
22nd Nov 20233:01 pmRNSDirector/PDMR Shareholding
25th Oct 20231:10 pmRNSHolding(s) in Company
24th Oct 202311:35 amRNSDirector/PDMR Shareholding
17th Oct 202310:01 amRNSMajor Shareholding Notifications
17th Oct 20237:00 amRNS4th Quarter Results
22nd Sep 202310:33 amRNSDirector/PDMR Shareholding
23rd Aug 202312:09 pmRNSDirector/PDMR Shareholding
24th Jul 20235:47 pmRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNS3rd Quarter Results
7th Jul 20238:18 amRNSAppointment of Chief Financial Officer
3rd Jul 20232:09 pmRNSDirector/PDMR Shareholding
26th Jun 20235:34 pmRNSDirector/PDMR Shareholding
26th Jun 20232:50 pmRNSDirector/PDMR Shareholding - Replacement
22nd Jun 20232:03 pmRNSDirector/PDMR Shareholding
12th Jun 20234:41 pmRNSHolding(s) in Company
2nd Jun 20235:30 pmRNSHolding(s) in Company
2nd Jun 20235:23 pmRNSHolding(s) in Company
26th May 20237:00 amRNSHalf-year Report
23rd May 20235:25 pmRNSHolding(s) in Company
23rd May 202311:53 amRNSDirector/PDMR Shareholding
16th May 202312:25 pmRNSHolding(s) in Company
10th May 20233:26 pmRNSHolding(s) in Company
3rd May 20234:20 pmRNSHolding(s) in Company
25th Apr 202311:38 amRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNS2nd Quarter Results
28th Mar 20233:18 pmRNSDirector/PDMR Shareholding
23rd Mar 20233:32 pmRNSDirector/PDMR Shareholding
23rd Feb 20235:16 pmRNSResult of AGM
22nd Feb 202310:39 amRNSDirector/PDMR Shareholding
9th Feb 20234:16 pmRNSHolding(s) in Company
31st Jan 202311:45 amRNSDirector/PDMR Shareholding
24th Jan 20235:09 pmRNSDirector/PDMR Shareholding
20th Jan 20239:33 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.